JPH02273685A - Production of diester compound - Google Patents
Production of diester compoundInfo
- Publication number
- JPH02273685A JPH02273685A JP1095485A JP9548589A JPH02273685A JP H02273685 A JPH02273685 A JP H02273685A JP 1095485 A JP1095485 A JP 1095485A JP 9548589 A JP9548589 A JP 9548589A JP H02273685 A JPH02273685 A JP H02273685A
- Authority
- JP
- Japan
- Prior art keywords
- phenylacetylamino
- compound
- reaction
- penicylanate
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 diester compound Chemical class 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000002904 solvent Substances 0.000 claims abstract description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004202 carbamide Substances 0.000 claims abstract description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical group 0.000 claims abstract description 3
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 3
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 3
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000011630 iodine Chemical group 0.000 claims description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 15
- 239000006227 byproduct Substances 0.000 abstract description 10
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract description 6
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 abstract description 4
- 229930182555 Penicillin Natural products 0.000 abstract description 3
- 229940049954 penicillin Drugs 0.000 abstract description 3
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical compound ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 description 8
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 229940126062 Compound A Drugs 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 description 4
- OPYGFNJSCUDTBT-PMLPCWDUSA-N sultamicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(=O)OCOC(=O)[C@H]2C(S(=O)(=O)[C@H]3N2C(C3)=O)(C)C)(C)C)=CC=CC=C1 OPYGFNJSCUDTBT-PMLPCWDUSA-N 0.000 description 4
- 229960001326 sultamicillin Drugs 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical group NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NKZMPZCWBSWAOX-IBTYICNHSA-M Sulbactam sodium Chemical compound [Na+].O=S1(=O)C(C)(C)[C@H](C([O-])=O)N2C(=O)C[C@H]21 NKZMPZCWBSWAOX-IBTYICNHSA-M 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- AKDMNWSBLXHXGL-RQJHMYQMSA-N chloromethyl (2s,5r)-3,3-dimethyl-4,4,7-trioxo-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound O=S1(=O)C(C)(C)[C@H](C(=O)OCCl)N2C(=O)C[C@H]21 AKDMNWSBLXHXGL-RQJHMYQMSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960005256 sulbactam Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KMEGBUCIGMEPME-LQYKFRDPSA-N (2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(1r,4s)-3,3-dimethyl-2,2,6-trioxo-2$l^{6}-thiabicyclo[3.2.0]heptane-4-carboxylic acid Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)C2C(=O)C[C@H]21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 KMEGBUCIGMEPME-LQYKFRDPSA-N 0.000 description 1
- NYCCIHSMVNRABA-UHFFFAOYSA-N 1,3-diethylimidazolidin-2-one Chemical compound CCN1CCN(CC)C1=O NYCCIHSMVNRABA-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 239000003781 beta lactamase inhibitor Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- PJGJQVRXEUVAFT-UHFFFAOYSA-N chloroiodomethane Chemical compound ClCI PJGJQVRXEUVAFT-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 description 1
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、ペニシリン系抗菌剤の合成中間体として有用
なジエステル化合物の改良された製造法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to an improved method for producing diester compounds useful as intermediates for the synthesis of penicillin antibacterial agents.
ペニシラン酸1.1−ジオキサイド(スルバクタム)は
有用なβ−ラクタマーゼ阻害剤として知フェノキシアセ
チルアミノを、Y2は硫黄、スルられている、また、そ
のスルバクタムとアンピシリンとをエステル結合させた
相互プロトラングである1、1−ジオキソペニシラノイ
ルオキシメチル・6− CD−(2−アミノ−2−フェ
ニルアセチルアミノ)〕ペニシラネート (スルタミシ
リン)は、アンピシリンおよびスルバクタムの血中1度
と組織内濃度の向上や生体内でのβ−ラクタマーゼ産生
のアンピシリン耐性菌に対する相互の協力作用の発現を
目的として開発された経口抗菌剤である。Penicillanic acid 1,1-dioxide (sulbactam) is known as a useful β-lactamase inhibitor. It contains phenoxyacetylamino, Y2 is sulfur, and it is also a mutual protrangyl compound in which sulbactam and ampicillin are ester bonded. 1,1-Dioxopenicilanoyloxymethyl 6-CD-(2-amino-2-phenylacetylamino)]penicillinate (sultamicillin) is a drug that increases blood and tissue concentrations of ampicillin and sulbactam. It is an oral antibacterial agent developed with the aim of exhibiting a mutually cooperative effect on ampicillin-resistant bacteria and β-lactamase production in vivo.
そして、スルタミシリン合成のための重要な合成中間体
として、1.1−ジオキソペニシラノイルオキシメチル
−6−(2−フェニルまたはフェノキシアセチルアミノ
)ペニシラネート(以下、化合物AまたはBという。)
などのジエステル化合物が知られている。And, as an important synthetic intermediate for the synthesis of sultamicillin, 1,1-dioxopenicilanoyloxymethyl-6-(2-phenyl or phenoxyacetylamino)penicillate (hereinafter referred to as compound A or B)
Diester compounds such as
特開昭55157589号公報には、ジメチルスルホキ
シド中、ペニシリンGカリウムとクロロメチル・ペニシ
ラネート1.1−ジオキサイドを反応させて化合物Aの
ジエステル化合物を得る方法が開示れている。JP-A-55157589 discloses a method for obtaining a diester compound of Compound A by reacting potassium penicillin G with chloromethyl penicillanate 1,1-dioxide in dimethyl sulfoxide.
また、特開昭59−98090号公報には、化合物Aま
たはBからスルタミシリンを製造する方法が開示されて
いるが、その中で、実施例1としてジメチルスルホキシ
ド中、ペニシリンGナトリウムとクロロメチル・ペニシ
ラネート1.1−ジオキサイドを反応させて化合物Aの
ジエステル化合物を得る方法が、さらに、実施例2(b
)としてアセトン中、クロロメチル・6−(2−フェニ
ルアセチルアミノ)ペニシラネートとテトラブチルアン
モニウム・ペニシラネート1,1−ジオキサイドを反応
させて化合物Aのジエステル化合物を得る方法が開示さ
れている。Further, JP-A-59-98090 discloses a method for producing sultamicillin from compound A or B, in which, as Example 1, sodium penicillin G and chloromethyl penicillinate in dimethyl sulfoxide are disclosed. The method for obtaining the diester compound of compound A by reacting 1.1-dioxide is further described in Example 2 (b
) discloses a method for obtaining a diester compound of Compound A by reacting chloromethyl 6-(2-phenylacetylamino)penicylanate and tetrabutylammonium penicylanate 1,1-dioxide in acetone.
これら、従来のジエステル化合物の製造法は、−aに収
率が低い。たとえば、特開昭55−157589号公報
の方法によれば、クロロメチル・ペニシラネート1.1
−ジオキサイドを基準として、ジエステル化合物の収率
が約12%と非常に低く、特開昭59−9809G号公
報の実施例1の方法においては、クロロメチル・ペニシ
ラネート1.1−ジオキサイドを基準として、ジエステ
ル化合物の収率が25.6%、実施例2(b)の方法に
おいては収率が45%といずれも工業的に満足されるも
のではなかった。These conventional methods for producing diester compounds have low yields in -a. For example, according to the method disclosed in JP-A-55-157589, chloromethyl penicillanate 1.1
-The yield of the diester compound is very low at about 12% based on chloromethyl penicylate 1,1-dioxide in the method of Example 1 of JP-A-59-9809G. In the method of Example 2(b), the yield of the diester compound was 25.6%, and the yield was 45% in the method of Example 2(b), both of which were not industrially satisfactory.
また、上記方法により得られるジエステル化合物はいず
れも泡状物質として得られ、目的物の分離、精製が煩雑
なものとなっていた。Furthermore, all of the diester compounds obtained by the above methods are obtained as foamy substances, making separation and purification of the target products complicated.
さらに、従来の溶媒、たとえば、ジメチルスルホキシド
の存在下で、本発明者らが追試したところによると、収
率が低いこと、目的物が泡状でしか得られないことと共
に、分解生成物と考えられる構造未知の副生物が相当程
度生成し、目的物の分離、精製をより困難なものとして
いた。Furthermore, in the presence of conventional solvents such as dimethyl sulfoxide, the inventors conducted additional tests and found that the yield was low and the desired product was obtained only in the form of foam, and that it was thought to be a decomposition product. A considerable amount of by-products of unknown structure were produced, making separation and purification of the target product more difficult.
したがって、これらのジエステル化合物を収率よく、副
生物の生成もなく、かつ、効率よく分離、精製できるよ
うな工業的製法の開発が望まれていた。Therefore, it has been desired to develop an industrial production method that can efficiently separate and purify these diester compounds in good yields and without producing by-products.
(課題が解決するための手段〕
そこで、本発明者らは、上記課題を解決するために鋭意
検討した結果、上述の反応中、溶媒として尿素系溶媒を
用いることにより、収率よく、副生物の生成もなく、し
かも、効率よく分離、精製が可能な一般式(り
(式中、Rはフェニルアセチルアミン、フェノキシアセ
チルアミノを示す。)
により表わされるジエステル化合物が得られるこを見い
出して、本発明を完成するに至った。(Means for Solving the Problems) Therefore, as a result of intensive studies to solve the above problems, the present inventors found that by using a urea-based solvent as a solvent during the above reaction, by-products can be produced in good yield. The present inventors have discovered that a diester compound represented by the general formula (wherein R represents phenylacetylamine or phenoxyacetylamino) can be obtained without the formation of The invention was completed.
すなわち、本発明は一般式(n)
(式中、R1は水素、フェニルアセチルアミノ、フェノ
キシアセチルアミンを、y+ は硫黄、スルホニルを、
Xは塩素、臭素、ヨウ素を示す。)により表わされる化
合物と一般式(III)(式中、R1は水素、フェニル
アセチルアミノ、フェノキシアセチルアミノを、Y2は
硫黄、スルホニルを、Mはアルカリ金属を示す。)によ
り表わされる化合物とを尿素系溶媒の存在下に反応させ
ることを特徴とする一般式(りにより表わされるジエス
テル化合物の製造法に関する。That is, the present invention relates to the general formula (n) (wherein, R1 is hydrogen, phenylacetylamino, phenoxyacetylamine, y+ is sulfur, sulfonyl,
X represents chlorine, bromine, or iodine. ) and a compound represented by the general formula (III) (wherein R1 represents hydrogen, phenylacetylamino, or phenoxyacetylamino, Y2 represents sulfur or sulfonyl, and M represents an alkali metal) as urea. The present invention relates to a method for producing a diester compound represented by the general formula (RI), which is characterized by carrying out the reaction in the presence of a system solvent.
本発明の製造法をさらに詳細に説明すると、出発原料で
ある一般式(II)の化合物は、工業的原料として安価
に入手できるペニシリンG、ペニシリン■やペニシラン
酸1.1−ジオキサイドを用いて、従来法および特願昭
62−298083号公報に記載の方法でメチレンクロ
ライド、クロロヨードメタン、ブロモクロロメタンなど
と反応させることより容易に合成させることができる。To explain the production method of the present invention in more detail, the starting material, the compound of general formula (II), is prepared using penicillin G, penicillin II, or penicillanic acid 1,1-dioxide, which are available at low cost as industrial raw materials. can be easily synthesized by reacting with methylene chloride, chloroiodomethane, bromochloromethane, etc., using conventional methods or the method described in Japanese Patent Application No. 62-298083.
もう一方の出発原料である一般式(1)の化合物は、水
溶性のものならばいずれでも使用することができ、アル
カリ金属塩として好ましくはナトリウム塩、カリウム塩
などが挙げられる。As the compound of general formula (1), which is the other starting material, any water-soluble compound can be used, and the alkali metal salts include preferably sodium salts, potassium salts, and the like.
本発明の特徴である反応溶媒は尿素系溶媒であってテト
ラメチル尿素、1,3−ジメチル−2=イミダゾリジノ
ン、1,3−ジエチル−2−イミダゾリジノン、・1,
3−ジプロピル−2−イミダゾリジノンなどが挙げられ
、これらを単独または混合溶媒として使用することもで
きる。The reaction solvent that is a feature of the present invention is a urea-based solvent such as tetramethylurea, 1,3-dimethyl-2-imidazolidinone, 1,3-diethyl-2-imidazolidinone, .1,
Examples include 3-dipropyl-2-imidazolidinone, which can be used alone or as a mixed solvent.
さらに、本発明の尿素系溶媒は回収も容易で再利用する
ことも可能である。Furthermore, the urea-based solvent of the present invention can be easily recovered and reused.
また、反応にヨウ化ナトリウムまたはヨウ化カリウムを
添加することにより、反応を円滑に進行させることがで
きる。その使用量は化合物(III)に対し、0.1倍
モル〜等モル程度である。Furthermore, by adding sodium iodide or potassium iodide to the reaction, the reaction can proceed smoothly. The amount used is approximately 0.1 times mole to equimole relative to compound (III).
さらに、同時に反応系にチオ硫黄ナトリウムを添加する
ことにより、反応液の着色防止、反応液の安定化、副生
物の生成防止などの効果が認められる。その使用量は、
化合物(In)に対し、0.1倍モル〜等モル程度であ
る。Furthermore, by simultaneously adding sodium thiosulfur to the reaction system, effects such as preventing coloring of the reaction solution, stabilizing the reaction solution, and preventing the production of by-products are observed. Its usage is
The amount is approximately 0.1 times mole to equimole relative to the compound (In).
反応温度は、室温から60℃の範囲で、好ましくは加温
下30〜250℃で行なわれる、反応時間は、添加物の
使用量、反応温度などにより変わり得るが、通常、1〜
24時間で行なうことかで。The reaction temperature ranges from room temperature to 60°C, preferably 30 to 250°C with heating.The reaction time may vary depending on the amount of additives used, the reaction temperature, etc., but is usually 1 to 250°C.
It will be done in 24 hours.
きる。また、原料化合物の量比は好ましくは等モルであ
る。Wear. Moreover, the quantitative ratio of the raw material compounds is preferably equimolar.
このようにして得られた一般式(1)のジエステル化合
物は、反応終了後、沈澱、蒸留、濾過、再結晶、カラム
クロマトグラフィーなどの常法により、単離、精製する
ことができる。After completion of the reaction, the diester compound of general formula (1) thus obtained can be isolated and purified by conventional methods such as precipitation, distillation, filtration, recrystallization, and column chromatography.
たとえば、反応液が化合物Aの場合には、反応終了後、
過剰の水の中に冷時注加することにより、目的物を結晶
として容易に単離することができる。For example, when the reaction solution is compound A, after the reaction is completed,
The desired product can be easily isolated as crystals by cold pouring into excess water.
本発明の方法によれば、
(1)高収率、高純度で目的物が得られる、(2)生成
物を結晶として単離することができ、得られたものも高
純度であるので、さらに精製する必要もなく、精製操作
が短縮できる、
(3)構造未知の副生物も生成せず、反応を円滑に進行
させることができ、同時に反応時間も短縮できる、
など、収率、純度、反応操作の点で利点を有し、ペニシ
リン系抗菌剤、特にスルタミシリンの合成中間体として
有用なジエステル化合物を有利に製造することができる
。According to the method of the present invention, (1) the target product can be obtained in high yield and high purity; (2) the product can be isolated as crystals, and the obtained product is also highly pure; There is no need for further purification, and the purification operation can be shortened. (3) No by-products with unknown structure are generated, the reaction can proceed smoothly, and at the same time, the reaction time can be shortened. Yield, purity, etc. It is possible to advantageously produce a diester compound which has advantages in terms of reaction operation and is useful as a synthetic intermediate for penicillin antibacterial agents, particularly sultamicillin.
以下、実施例により本発明を具体的に説明するが、本発
明はそれらによって何ら限定されるものではない、なお
、得られた化合物はIRスペクトル、NMRスペクトル
、HPLC,元素分析などの手段により目的化合物であ
ることを確認した。Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto. It should be noted that the obtained compounds were analyzed by means such as IR spectrum, NMR spectrum, HPLC, elemental analysis, etc. It was confirmed that it was a compound.
参考例1:クロロメチル・6−(2−フェニルアセチル
アミノ)ペニシラネート
ブロモクロロメタン300aw、水10gおよび50.
9%テトラブチルアンモニウムブロマイド1.3gの混
合物を45℃に保ち、これにカリウム6−(2−フェニ
ルアセチルアミノ)ペニシラネ−ドア、 45 g、水
40gおよび重炭酸カリウム0.2g(7)溶液を注加
した。激しく攪拌しながら45℃で8時間反応した0反
応終了後の反応液中の組成は、カリウム6−(2−フェ
ニルアセチルアミ゛))ペニシラネート:クロロメチル
・6−(2−フェニルアセチルアミノ)ペニシラネート
:メチレンビス(6−(2−フェニルアセチルアミノ)
ペニシラネート) −6,5: 85.6 : 7.9
(HPLC面積比)であった0反応液を冷却し、有機
層を分取し水洗した後、減圧下濃縮して淡褐色の油状物
7.4gを得る。この油状物の組成は、カリウム6−(
2−フェニルアセチルアミノ)ペニシラネート:クロロ
メチル・6−(2−フェニルアセチルアミノ)ペニシラ
ネート:メチレンビス〔6−(2−フェニルアセチルア
ミノ)ペニシラネート)−0,23:85.63:9.
87 ()(PLC面積比)、であった。Reference Example 1: Chloromethyl 6-(2-phenylacetylamino)penicylanate bromochloromethane 300 aw, water 10 g and 50.
A mixture of 1.3 g of 9% tetrabutylammonium bromide kept at 45°C was added with a solution of 45 g of potassium 6-(2-phenylacetylamino)penicillane door, 40 g of water and 0.2 g of potassium bicarbonate (7). Added. After the reaction was completed at 45°C for 8 hours with vigorous stirring, the composition of the reaction solution was potassium 6-(2-phenylacetylamino))penicylanate: chloromethyl 6-(2-phenylacetylamino)penicylanate. : Methylenebis(6-(2-phenylacetylamino)
penicillanate) -6,5: 85.6: 7.9
The reaction solution (HPLC area ratio) was 0, and the organic layer was separated, washed with water, and concentrated under reduced pressure to obtain 7.4 g of a pale brown oil. The composition of this oil is potassium 6-(
2-phenylacetylamino)penicylanate: chloromethyl 6-(2-phenylacetylamino)penicylanate: methylenebis[6-(2-phenylacetylamino)penicylanate)-0,23:85.63:9.
87 ( ) (PLC area ratio).
参考例2zクロロメチル・ペニシラネート1,1−ジオ
キサイド
ブロモクロロメタン300g、水5gおよび50、9
gテトラブチルアンモニウムブロマイド0.65gの混
合物を50℃に保ち、これにペニシラン酸ナトリウム1
,1−ジオキサイド2.55g。Reference Example 2z Chloromethyl penicillanate 1,1-dioxide 300 g of bromochloromethane, 5 g of water and 50,9
g A mixture of 0.65 g of tetrabutylammonium bromide was kept at 50°C, and 1 part of sodium penicillanate was added to it.
, 2.55 g of 1-dioxide.
水20gおよび炭酸カリウム0.67 gの溶液を注加
した。激しく撹拌しながら50℃で200時間反応た。A solution of 20 g of water and 0.67 g of potassium carbonate was added. The reaction was carried out at 50° C. for 200 hours with vigorous stirring.
有機層を分取し水洗した後、ブロモクロロメタンを留去
した。残留物の組成はクロロメチル・ペニシラネート1
.1−ジオキサイド:メチレンビス〔1,1−ジオキソ
ペニシラネート〕−93,18: 6.82 (HPL
C面積比)であった。After the organic layer was separated and washed with water, bromochloromethane was distilled off. The composition of the residue is chloromethyl penicillate 1
.. 1-dioxide: methylene bis[1,1-dioxopenicillanate]-93,18: 6.82 (HPL
C area ratio).
残留物の一部を冷蔵庫に放置すると結晶化した。A portion of the residue crystallized when left in the refrigerator.
その結晶を濾取し、少量のエーテル−石油エーテル混合
溶媒で洗浄すると、融点94〜96℃の目的物結晶を得
た。The crystals were collected by filtration and washed with a small amount of ether-petroleum ether mixed solvent to obtain target crystals with a melting point of 94 to 96°C.
実施例1
参考例1と同様の操作により得られた組成りロロメチル
・6−(2−フェニルアセチルアミノ)ペニシラネート
:メチレンビス(6−(2−フェニルアセチルアミノ)
ペニシラネート)−97,81,2(HPLC面積比)
の油状物7.6gt−1,3=ジメチル−2−イミダゾ
リジノン25gに溶かし、ヨウ化カリウム5g、ペニシ
ラン酸ナトリウム1,1−ジオキサイド5.1gおよび
チオ硫酸ナトリウム0.6gを加えて、40℃で反応し
た。Example 1 Composition obtained by the same operation as in Reference Example 1 Lolomethyl 6-(2-phenylacetylamino)penicylanate: methylenebis(6-(2-phenylacetylamino)
penicillanate)-97,81,2 (HPLC area ratio)
Dissolve 7.6g of oil in 25g of 1,3-dimethyl-2-imidazolidinone, add 5g of potassium iodide, 5.1g of sodium penicillanate 1,1-dioxide and 0.6g of sodium thiosulfate. The reaction was carried out at 40°C.
HPLCで反応が終了したことを確認した後、反応液を
冷水150g中に注加した。析出した結果が水冷時熟成
した後に濾取し、水洗後、五酸化リン上で乾燥すると、
淡褐色の結晶性粉末10.8 gが得られた。この結晶
性粉末の組成は、1.1ジオキソペニシラノイルオキシ
メチル・6−(2−フェニルアセチルアミノ)ペニシラ
ネート:メチレンビス(6−(2−フェニルアセチルア
ミノ)ペニシラネー)):1,3−ジメチル−2−イミ
ダゾリジノン:水−88,8: 3.4 : 6.8
: 1.0(HPLC面積比)であり、その他の構造未
知の副生物は全く検出されなかった。After confirming the completion of the reaction by HPLC, the reaction solution was poured into 150 g of cold water. The precipitated result is aged by water cooling, collected by filtration, washed with water, and dried over phosphorus pentoxide.
10.8 g of light brown crystalline powder was obtained. The composition of this crystalline powder is 1.1 dioxopenicilanoyloxymethyl 6-(2-phenylacetylamino)penicillane: methylenebis(6-(2-phenylacetylamino)penicillane)): 1,3-dimethyl -2-imidazolidinone: water-88,8: 3.4: 6.8
: 1.0 (HPLC area ratio), and no other structurally unknown by-products were detected.
実施例2
参考例2と同様の操作により得られた組成りロロメチル
・ペニシラネート1.1−ジオキサイド:メチレンビス
〔1,1−ジオキソペニシラネート)−96,3F 3
.7 (HPLC面積比)の粘稠油状物5.6gを1.
3−ジメチル−2−イミダゾリジノン25gに溶かし、
ヨウ化カリウム5g1カリウム6−(2−フェニルアセ
チルアミノ)ペニシラネート7.4gおよびチオ硫酸ナ
トリウム0.6gを加えて40℃で反応した。HPLC
で反応が終了したことを確認した後、冷水150g中に
注加した。析出した結晶が水冷時熟成した後、濾取し、
水洗後、五酸化リン上で乾燥すると淡褐色の結晶性粉末
10.5 gが得られた。この結晶性粉末の組成は、1
.1−ジオキソペニシラノイルオキシメチル・6−(2
−フェニルアセチルアミノ)ペニシラネート:メチレン
ビス〔1,1−ジオキソペニシラネート)il、3−ジ
メチル−2−イミダゾリジノン:水−87,8: 3.
8 : 7.2 : 1.2(HPLC面積比)であり
、その他の構造未知の副生物は全く検出されなかった。Example 2 Composition obtained by the same operation as in Reference Example 2 Lolomethyl penicillate 1,1-dioxide: methylenebis[1,1-dioxopenicilanato)-96,3F 3
.. 7 (HPLC area ratio) 5.6 g of viscous oil was added to 1.
Dissolved in 25 g of 3-dimethyl-2-imidazolidinone,
5 g of potassium iodide, 7.4 g of potassium 6-(2-phenylacetylamino)penicylanate and 0.6 g of sodium thiosulfate were added and reacted at 40°C. HPLC
After confirming that the reaction was completed, the mixture was poured into 150 g of cold water. After the precipitated crystals mature during water cooling, they are collected by filtration,
After washing with water and drying over phosphorus pentoxide, 10.5 g of light brown crystalline powder was obtained. The composition of this crystalline powder is 1
.. 1-Dioxopenicilanoyloxymethyl 6-(2
-phenylacetylamino)penicylanate: methylenebis[1,1-dioxopenicylanate)il, 3-dimethyl-2-imidazolidinone: water-87,8: 3.
The ratio was 8:7.2:1.2 (HPLC area ratio), and no other by-products of unknown structure were detected.
実施例3
参考例1と同様の操作により得られた組成りロロメチル
・6−(2−フェニルアセチルアミノ)ペニシラネート
:メチレンビス(6−(2−フェニルアセチルアミノ)
ペニシラネート)−90,21,8(HPLC面積比)
の油状物7.6gをテトラメチル尿素30gに溶かし、
ヨウ化カリウム3.3g、ペニシラン酸ナトリウム1.
1−ジオキサイド5.1gを加えて、45℃で13時間
反応した。冷却後、反応液を冷水150g中に注加した
。Example 3 Composition obtained by the same operation as Reference Example 1 Lolomethyl 6-(2-phenylacetylamino)penicylanate: Methylenebis(6-(2-phenylacetylamino)
penicillanate) -90,21,8 (HPLC area ratio)
Dissolve 7.6g of the oil in 30g of tetramethylurea,
Potassium iodide 3.3g, sodium penicillanate 1.
5.1 g of 1-dioxide was added and reacted at 45° C. for 13 hours. After cooling, the reaction solution was poured into 150 g of cold water.
析出した結晶が水冷時熟成した後、濾取した。水洗後、
五酸化リン上で乾燥すると淡褐色の結晶性粉末10.6
gが得られる。この結晶性粉末の組成は1.1−ジオ
キソペニシラノイルオキシメチル・6−(2−フェニル
アセチルアミノ)ペニシラネート:メチレンビス(6−
(2−フェニルアセチルアミン)ペニシラネート〕 :
テトラメチル尿素:水−83.1 : 8.2 : 7
.2 : 1.5 (HPLC面積比)であり、その他
の構造未知の副生物は全く検出されなかった。The precipitated crystals were aged during cooling with water and then collected by filtration. After washing with water,
Light brown crystalline powder when dried over phosphorus pentoxide 10.6
g is obtained. The composition of this crystalline powder is 1.1-dioxopenicilanoyloxymethyl 6-(2-phenylacetylamino)penicylanate: methylenebis(6-
(2-phenylacetylamine) penicillate]:
Tetramethylurea: water - 83.1: 8.2: 7
.. 2:1.5 (HPLC area ratio), and no other structurally unknown by-products were detected.
実施例4
参考例1と同様の操作により得られた組成りロロメチル
・6−(2−フェニルアセチルアミノ)ペニシラネート
:メチレンビス(6−(2−フェニルアセチルアミノ)
ペニシラネート)−97,71,3(HPLC面積比)
の油状物7.6gを1.3−ジメチル−2−イミダゾリ
ジノン25gに溶かし、ヨウ化カリウム5g、ペニシラ
ン酸ナトリウム1,1−ジオキサイド5.1gおよびチ
オ硫酸ナトリウム1.6gを加えて、45℃で6時間反
応した0反応液を実施例1と同様に処理して得られた結
晶性粉末の組成は1.1−ジオキソペニシラノイルオキ
シメチル・6−(2−フェニルアセチルアミノ)ペニシ
ラネート:メチレンビス〔6−(2−フェニルアセチル
アミノ)ペニシラネート〕−95,6: 4.4 (H
PLC面積比)であり、その他の構造未知の副生物は全
く検出されなかった。Example 4 Composition obtained by the same operation as in Reference Example 1 Lolomethyl 6-(2-phenylacetylamino)penicylanate: Methylenebis(6-(2-phenylacetylamino)
penicillanate) -97,71,3 (HPLC area ratio)
Dissolve 7.6 g of the oil in 25 g of 1,3-dimethyl-2-imidazolidinone, add 5 g of potassium iodide, 5.1 g of sodium penicillanate 1,1-dioxide, and 1.6 g of sodium thiosulfate. The composition of the crystalline powder obtained by treating the 0 reaction solution reacted at 45°C for 6 hours in the same manner as in Example 1 is 1.1-dioxopenicilanoyloxymethyl 6-(2-phenylacetylamino). Penicylanate: Methylenebis[6-(2-phenylacetylamino)penicylanate]-95,6: 4.4 (H
(PLC area ratio), and no other structurally unknown by-products were detected.
Claims (1)
ノキシアセチルアミノを、Y^1は硫黄、スルホニルを
、Xは塩素、臭素、ヨウ素を示す。)により表わされる
化合物と一般式 ▲数式、化学式、表等があります▼ (式中、R^2は水素、フェニルアセチルアミノ、フェ
ノキシアセチルアミノを、Y^2は硫黄、スルホニルを
、Mはアルカリ金属を示す。) により表わされる化合物とを尿素系溶媒の存在下に反応
させることを特徴とする一般式 ▲数式、化学式、表等があります▼ (式中、Rはフェニルアセチルアミノ、フェノキシアセ
チルアミノを示す。) により表わされるジエステル化合物の製造法。(1) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R^1 is hydrogen, phenylacetylamino, phenoxyacetylamino, Y^1 is sulfur, sulfonyl, and X is chlorine, bromine, iodine. ) and general formulas ▲ mathematical formulas, chemical formulas, tables, etc. represents an alkali metal) in the presence of a urea-based solvent ▲ There are mathematical formulas, chemical formulas, tables, etc. A method for producing a diester compound represented by (representing acetylamino).
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1095485A JPH02273685A (en) | 1989-04-14 | 1989-04-14 | Production of diester compound |
GB9008395A GB2231049A (en) | 1989-04-14 | 1990-04-12 | Method for producing diester compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1095485A JPH02273685A (en) | 1989-04-14 | 1989-04-14 | Production of diester compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02273685A true JPH02273685A (en) | 1990-11-08 |
Family
ID=14138910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1095485A Pending JPH02273685A (en) | 1989-04-14 | 1989-04-14 | Production of diester compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02273685A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101142582B1 (en) * | 2003-11-28 | 2012-05-03 | 체지앙 용닝 파마슈티컬 컴퍼니 리미티드 | ?-lactamase-resistant cephalosporin ester compounds and salts of thereof |
-
1989
- 1989-04-14 JP JP1095485A patent/JPH02273685A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101142582B1 (en) * | 2003-11-28 | 2012-05-03 | 체지앙 용닝 파마슈티컬 컴퍼니 리미티드 | ?-lactamase-resistant cephalosporin ester compounds and salts of thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021514371A (en) | Method for Producing Prostaglandin Analogs That Donate Nitric Oxide | |
JPS5940813B2 (en) | Magnesium compounds and their production method | |
KR20020068517A (en) | Crystals of penicillin and process for the production thereof | |
JPH02273685A (en) | Production of diester compound | |
JPS6332791B2 (en) | ||
JPH0383988A (en) | Production of diester compound | |
GB2231049A (en) | Method for producing diester compounds | |
JPH01139584A (en) | Production of penicillanic acid compound | |
KR910001309B1 (en) | Process for preparing penicillanic acid compounds | |
JPS6053039B2 (en) | N-Acetyl/Iramic acid derivative and method for producing the same | |
US3308132A (en) | 6, 8-dithiooctanoyl amides and intermediates | |
JPH08208591A (en) | 2-aminobenzenesulfonic acid derivative and 2-aminobenzenesulfonyl chloride,derivative their production,and their use as synthetic intermediates | |
JPS63170384A (en) | 7alpha-substituted cephalosporin compound | |
JPS63503072A (en) | New and improved synthetic method for penicillanic acid derivatives | |
JPS6019312B2 (en) | Method for producing oxazolinoazetidinylpentenoic acid derivatives | |
JPH0812658A (en) | Production of sydnones | |
JPS59155390A (en) | Manufacture of 3-methylenecepham compound | |
JPS6127961A (en) | Preparation of n-substituted phthalimide | |
JPS60169493A (en) | Preparation of 5-deoxy-l-arabinose | |
JPH075563B2 (en) | Disulfide derivative and method for producing the same | |
JPS59128387A (en) | Manufacture and intermediate of 1'-ethoxycarbonyl oxyethyl ester of penicillin | |
JP2003183245A (en) | Method of production for aryl sulfone | |
JPS60228486A (en) | Novel process for preparing cephalosporin | |
JPS62267267A (en) | Pyrazole derivative and production thereof | |
JPS6289689A (en) | Novel method for producing cephalo-type antibiotic substance |